Oscar L. Lopez

University Of Pittsburgh At Pittsburgh

$26,660,804

Attributed

$36,444,835

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $12.9M · FY2005–25

$20M$15M$10M$5M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$85,180,215 · 22

By mechanism

P50$32,316,709 · 4

P30$24,690,398 · 4

U01$11,805,776 · 2

RF1$9,322,123 · 1

R01$3,719,913 · 1

P01$2,795,267 · 4

Top collaborators

Most similar at University Of Pittsburgh At Pittsburgh

Same institution · by research overlap

Theresa L. Whiteside$29,550,469
Milos D Ikonomovic$11,868,106
Gulnaz Begum$2,129,850
Edwin K Jackson$26,285,581
Robert H. Getzenberg$8,211,645

Others in their field

Top investigators on “Alzheimer&Apos”

Jose A Luchsinger · Columbia University Health Sciences$56,595,040
Eric M Reiman · Banner Health$48,982,487
Yadong Huang · J. David Gladstone Institutes$40,311,515
Lindsay A. Farrer · Boston University Medical Campus$34,189,802
David M Holtzman · Washington University$28,985,806
Michael W Weiner · Northern California Institute Res &Educ$28,197,224

Research focus

Alzheimer&AposDementiaS DiseaseNeuroimagingResearch PersonnelParticipantBrainGeneticFundingCognitiveAreaSamplingResourcesEvaluationCognitionMild Cognitive ImpairmentDatabasesImageCohortProgramsUniversitiesPositron-Emission TomographyFollow-UpAmyloid

Grant awards (75)

Alzheimer Disease Research Center$4,514,197

P30 · FY2025 · AG · contact PI

Dementia with Lewy Bodies Consortium$1,215,498

U01 · FY2025 · NS

Administrative Core$760,944

P30 · FY2025 · AG · contact PI

Alzheimer's Disease Research Center$3,098,848

P30 · FY2024 · AG · contact PI

Dementia with Lewy Bodies Consortium$2,250,274

U01 · FY2024 · NS

Administrative Core$774,485

P30 · FY2024 · AG · contact PI

Alzheimer's Disease Research Center$3,098,848

P30 · FY2023 · AG · contact PI

Dementia with Lewy Bodies Consortium$2,127,650

U01 · FY2023 · NS

Administrative Core$812,777

P30 · FY2023 · AG · contact PI

Alzheimer's Disease Research Center$3,083,406

P30 · FY2022 · AG · contact PI

Dementia with Lewy Bodies Consortium$2,091,032

U01 · FY2022 · NS

Administrative Core$816,220

P30 · FY2022 · AG · contact PI

Administrative Core$267,269

P30 · FY2022 · AG · contact PI

Admin Supplemental for ADRC Core D$267,269

P30 · FY2022 · AG · contact PI

Alzheimer's Disease Research Center$3,052,522

P30 · FY2021 · AG · contact PI

Administrative Core$279,296

P30 · FY2021 · AG · contact PI

Alzheimer's Disease Research Center$3,052,522

P30 · FY2020 · AG · contact PI

Administrative Core$566,905

P30 · FY2020 · AG · contact PI

Vascular Moderators of the Impact of Alzheimer's Pathology in the Oldest-Old$294,746

P01 · FY2020 · AG · contact PI

Comparison of tau-PET tracers: Progress towards a universal measure$244,890

P30 · FY2020 · AG · contact PI

Alzheimer's Disease Research Center$3,393,854

P50 · FY2019 · AG · contact PI

Core A: Administrative Core$360,956

P50 · FY2019 · AG · contact PI

Vascular Moderators of the Impact of Alzheimer's Pathology in the Oldest-Old$292,881

P01 · FY2019 · AG · contact PI

Subclinical vascular disease and AD pathology in the transition from midlife to old age$9,322,123

RF1 · FY2018 · AG · contact PI

Alzheimer's Disease Research Center$2,327,945

P50 · FY2018 · AG · contact PI

ADRC Neuroimaging Core F Revision$555,079

P50 · FY2018 · AG · contact PI

Core A: Administrative Core$360,957

P50 · FY2018 · AG · contact PI

Vascular Moderators of the Impact of Alzheimer's Pathology in the Oldest-Old$296,970

P01 · FY2018 · AG · contact PI

Alzheimer's Disease Research Center$2,331,138

P50 · FY2017 · AG · contact PI

Vascular Moderators of the Impact of Alzheimer's Pathology in the Oldest-Old$361,207

P01 · FY2017 · AG · contact PI

Core A: Administrative Core$360,956

P50 · FY2017 · AG · contact PI

Alzheimer's Disease Research Center$2,286,967

P50 · FY2016 · AG · contact PI

Vascular Moderators of the Impact of Alzheimer's Pathology in the Oldest-Old$367,967

P01 · FY2016 · AG · contact PI

Core A: Administrative Core$360,956

P50 · FY2016 · AG · contact PI

Alzheimer's Disease Research Center$2,271,968

P50 · FY2015 · AG · contact PI

Core A: Administrative Core$360,956

P50 · FY2015 · AG · contact PI

Alzheimer's Disease Research Center$2,193,709

P50 · FY2014 · AG · contact PI

ADMINISTRATIVE CORE$292,793

P50 · FY2014 · AG · contact PI

Modulators of Cognitive Transition from Normal to MCI$116,519

P01 · FY2014 · AG · contact PI

AMYLOID DEPOSTION, VASCULAR DISEASE AND CLINICAL PROGRESSION OF AD$104,307

P50 · FY2014 · AG · contact PI

Alzheimer's Disease Research Center$2,085,236

P50 · FY2013 · AG · contact PI

ADMINISTRATIVE CORE$275,524

P50 · FY2013 · AG · contact PI

Modulators of Cognitive Transition from Normal to MCI$222,856

P01 · FY2013 · AG · contact PI

AMYLOID DEPOSTION, VASCULAR DISEASE AND CLINICAL PROGRESSION OF AD$128,118

P50 · FY2013 · AG · contact PI

Alzheimer's Disease Research Center$2,252,865

P50 · FY2012 · AG · contact PI

ADMINISTRATIVE CORE$296,566

P50 · FY2012 · AG · contact PI

Modulators of Cognitive Transition from Normal to MCI$226,662

P01 · FY2012 · AG · contact PI

AMYLOID DEPOSTION, VASCULAR DISEASE AND CLINICAL PROGRESSION OF AD$156,159

P50 · FY2012 · AG · contact PI

Alzheimer's Disease Research Center$2,229,013

P50 · FY2011 · AG · contact PI

Predictors of Alheimers Disease in Mild Cognitive Impairment$359,595

R01 · FY2011 · AG · contact PI

ADMINISTRATIVE CORE$333,475

P50 · FY2011 · AG · contact PI

Modulators of Cognitive Transition from Normal to MCI$267,652

P01 · FY2011 · AG · contact PI

AMYLOID DEPOSTION, VASCULAR DISEASE AND CLINICAL PROGRESSION OF AD$148,564

P50 · FY2011 · AG · contact PI

CHS-COGNITION STUDY$20,271

P41 · FY2011 · RR · contact PI

CARDIOVASCULAR HEALTH STUDY (CHS)$10,135

P41 · FY2011 · RR · contact PI

Alzheimer's Disease Research Center$2,273,968

P50 · FY2010 · AG · contact PI

Predictors of Alheimers Disease in Mild Cognitive Impairment$427,752

R01 · FY2010 · AG · contact PI

Modulators of Cognitive Transition from Normal to MCI$347,807

P01 · FY2010 · AG · contact PI

ADMINISTRATIVE CORE$304,785

P50 · FY2010 · AG · contact PI

AMYLOID DEPOSTION, VASCULAR DISEASE AND CLINICAL PROGRESSION OF AD$148,759

P50 · FY2010 · AG · contact PI

CHS-COGNITION STUDY$9,118

P41 · FY2010 · RR · contact PI

Alzheimer's DIsease Research Center$2,089,551

P50 · FY2009 · AG · contact PI

Ginkgo Biloba Prevention Trial in Older Individuals$1,172,855

U01 · FY2009 · AT · contact PI

Predictors of Alheimers Disease in Mild Cognitive Impairment$404,281

R01 · FY2009 · AG · contact PI

CHS-COGNITION STUDY$3,406

P41 · FY2009 · RR · contact PI

Ginkgo Biloba Prevention Trial in Older Individuals$2,948,467

U01 · FY2008 · AT · contact PI

Alzheimer's DIsease Research Center$2,031,585

P50 · FY2008 · AG · contact PI

Predictors of Alheimers Disease in Mild Cognitive Impairment$414,082

R01 · FY2008 · AG · contact PI

CHS-COGNITION STUDY$5,153

P41 · FY2008 · RR · contact PI

Predictors of Alzheimers Disease in Mild Cognitive Impairment$481,946

R56 · FY2007 · AG · contact PI

Alzheimers Disease in Mild Cognitive Impairment$418,311

R01 · FY2006 · AG · contact PI

Alzheimers Disease in Mild Cognitive Impairment$411,305

R01 · FY2005 · AG

Alzheimers Disease in Mild Cognitive Impairment$414,284

R01 · FY2004 · AG

Alzheimers Disease in Mild Cognitive Impairment$413,501

R01 · FY2003 · AG

Alzheimers Disease in Mild Cognitive Impairment$456,802

R01 · FY2002 · AG